CCR5/CXCR3 antagonist TAK-779 prevents diffuse alveolar damage of the lung in the murine model of the acute respiratory distress syndrome

• Egile Nagusiak: Aleksandr S. Chernov (Egilea), Maksim V. Rodionov (Egilea), Vitaly A. Kazakov (Egilea), Karina A. Ivanova (Egilea), Fedor A. Meshcheryakov (Egilea), Anna A. Kudriaeva (Egilea), Alexander G. Gabibov (Egilea), Georgii B. Telegin (Egilea), Alexey A. Belogurov (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2024-02-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Introduction: The acute respiratory distress syndrome (ARDS), secondary to viral pneumonitis, is one of the main causes of high mortality in patients with COVID-19 (novel coronavirus disease 2019)-ongoing SARS-CoV-2 infection- reached more than 0.7 billion registered cases.Methods: Recently, we elab...